D'Amico AV - Search Results

1

A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.

Lago-Hernandez CA, Feldman H, O'Donnell E, Mahal BA, Perez V, Howard S, Rosenthal M, Cheng SC, Nguyen PL, Beard C, D'Amico AV, Sweeney CJ. Lago-Hernandez CA, et al. Ann Oncol. 2015 Jul;26(7):1396-401. doi: 10.1093/annonc/mdv180. Epub 2015 Apr 17. Ann Oncol. 2015. PMID: 25888612 Free PMC article.

2

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.

D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. D'Amico AV, et al. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1053-8. doi: 10.1016/s0360-3016(96)00633-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169812 Free article.

3

Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.

D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. D'Amico AV, et al. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):335-40. doi: 10.1016/s0360-3016(97)00320-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308936 Free article.

4

Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.

D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Wein A, Tomaszewski JE, Coleman CN. D'Amico AV, et al. Cancer. 1998 Jan 15;82(2):334-41. doi: 10.1002/(sici)1097-0142(19980115)82:2<342::aid-cncr14>3.0.co;2-z. Cancer. 1998. PMID: 9445191

5

Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer.

Beard CJ, Lamb C, Buswell L, Schneider L, Propert KJ, Gladstone D, D'Amico A, Kaplan I. Beard CJ, et al. Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):257-62. doi: 10.1016/s0360-3016(98)00054-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9607338

6

Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapy.

D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Loughlin KR, Richie JP, Wein A. D'Amico AV, et al. J Clin Oncol. 1998 Sep;16(9):3094-100. doi: 10.1200/JCO.1998.16.9.3094. J Clin Oncol. 1998. PMID: 9738580

7

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. D'Amico AV, et al. JAMA. 1998 Sep 16;280(11):969-74. doi: 10.1001/jama.280.11.969. JAMA. 1998. PMID: 9749478

8

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, Beard CJ, Tomaszewski JE, Renshaw AA, Wein A, Coleman CN. D'Amico AV, et al. J Clin Oncol. 1999 Jan;17(1):168-72. doi: 10.1200/JCO.1999.17.1.168. J Clin Oncol. 1999. PMID: 10458230

9

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.

D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. D'Amico AV, et al. JAMA. 2000 Sep 13;284(10):1280-3. doi: 10.1001/jama.284.10.1280. JAMA. 2000. PMID: 10979115

10

Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.

D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, Kantoff PW, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. D'Amico AV, et al. J Clin Oncol. 2000 Sep 15;18(18):3240-6. doi: 10.1200/JCO.2000.18.18.3240. J Clin Oncol. 2000. PMID: 10986056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page